Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06068153
Title AMG510 (Sotorasib) Plus Lenvatinib as Second-line Treatment in Patients With KRASG12C Mutant, Metastatic NSCLC (AMBER)
Acronym AMBER
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors ETOP IBCSG Partners Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | DEU | CHE | AUT


No variant requirements are available.